Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment
Ruyin Chen(First Affiliated Hospital Zhejiang University), Jian Ruan(TCM-Intigrated Cancer Center of Southern Medical University)
Cited by 47
Related Papers
FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
|Cancer Cell International|2020|12